The prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic women.
A group of 106 consecutively seen hyperandrogenic women were subjected to an acute adrenal suppression and stimulation test. The results of these tests were analyzed with respect to androgen suppression achieved after chronic glucocorticoid therapy in the same patients. The data suggested that an acute dexamethasone test may identify the group of hyperandrogenic women who respond poorly to chronic glucocorticoid therapy. This group of patients were found to have elevated luteinizing hormone (LH) levels and LH/follicle-stimulating hormone (FSH) ratios, suggesting the possibility of an LH-related hyperandrogenism. In patients whose elevated testosterone levels were suppressed by dexamethasone, adrenocorticotropic hormone (ACTH) induced a prompt return of the testosterone levels to baseline, suggesting an ACTH-dependent hyperandrogenism. In these patients, the degree of testosterone suppression after dexamethasone was not quantitatively related to the degree of testosterone suppression after chronic glucocorticoid therapy. In all cases chronic therapy resulted in a greater suppression of androgen levels than the acute dexamethasone test. In conclusion, an acute dexamethasone suppression test appears to be of clinical value in the management of the hyperandrogenic female, particularly in identification of women who will not respond to chronic glucocorticoid suppression therapy.
D000324:Adrenocorticotropic Hormone; D000728:Androgens / Q000378:metabolism*; D003907:Dexamethasone; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013739:Testosterone / Q000097:blood; D014770:Virilism / Q000175:diagnosis* / Q000188:drug therapy
D000728:Androgens; D006065:Gonadotropins, Pituitary; D013739:Testosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D006854:Hydrocortisone